Germany Takes a Major Step Toward Access to TK2d Therapy
A significant milestone has been reached for families affected by TK2d: Germany has now formally recognised Kygevvi®, the first disease‑specific […]
Homepage News, Latest News, News
News
New Study Strengthens Patient‑Centred Endpoint Selection for KHENERFIN Phase 3 Trial
Khondrion has announced the publication of an important qualitative study in Orphanet Journal of Rare Diseases examining the lived experience
The Effects of Hydrogen Sulfide, VOCs and Bioaerosols on People with Mitochondrial Disease
Written by Paula Morandi, Chair of IMP Why emissions from olive‑pomace fermentation pose a serious health risk The open‑air fermentation
A note from the Chair: One Voice, 25 Nations — The Power of Our Global Umbrella
Paula Morandi, Chair of IMP When you hear the acronym IMP, what comes to mind? To many, International Mito Patients
Latest News, News
IMP Annual Meeting 2026 – Celebrating 15 years
The International Mito Patients (IMP) Annual Meeting 2026 brought together advocates, clinicians, researchers and partners from around the world to
Registration is now open for the TK2d International Webinar 2026 .
TK2d across countries: diagnosis, multidisciplinary care and therapeutic pathways Registration is now open for the international webinar “TK2d Across Countries: Diagnosis,
A word from our new member ASANOL
On 29 May, we had the opportunity to participate, for the first time as ASANOL, in the International Mito Patients meeting
World Mitochondrial Disease Week 2026: Putting Mito on the Map
We’re delighted to announce the launch of this year’s World Mitochondrial Disease Week theme: “Putting Mito on the Map.” Members asked
New Patient Journey for Primary Mitochondrial Myopathies Launched
IMP has worked with ERN EURO‑NMD and several leading patient organisations, including Mitocon, the Bulgarian Association for Neuromuscular Diseases, and
New TK2d Early Symptom Reflection Tool Supports Better Clinical Conversations
UMDF, in collaboration with UCB, has launched a new resource designed specifically for people living with TK2d and those who